Free Trial

Stock Price Targets and Analyst Ratings

CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetails
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
Downgraded byCitigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
$11.75
+1.9%
$12.00BuyNeutral
Avadel Pharmaceuticals PLC. stock logo
AVDL
Avadel Pharmaceuticals
Downgraded byHC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
$18.53
+0.0%
$20.00BuyNeutral
Enphase Energy, Inc. stock logo
ENPH
Enphase Energy
Downgraded byMizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
$35.36
-2.0%
$50.00 ➝ $37.00OutperformNeutral
Plymouth Industrial REIT stock logo
PLYM
Plymouth Industrial REIT
Downgraded byRobert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
$22.01
-0.5%
$19.00 ➝ $24.00OutperformNeutral
Vivid Seats Inc. stock logo
SEAT
Vivid Seats
Downgraded byCitigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
$13.52
+4.1%
$32.00 ➝ $13.00BuyNeutral
Take-Two Interactive Software, Inc. stock logo
TTWO
Take-Two Interactive Software
Downgraded byArete
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 $256.16
+0.2%
$280.00BuyNeutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 11:57 AM ET.